Performance of TECH Bio-Techne | 10% in 12m
Compare TECH with Indices, Sectors and Commodities ✔ like Oil, Gas, Gold, Yields and Bonds. Who outperforms?
Compare Bio-Techne with its related Sector/Index XLV
Performance Duell TECH vs XLV
| TimeFrame | TECH | XLV |
|---|---|---|
| 1 Week | -3.88% | -0.25% |
| 1 Month | -6.81% | -1.71% |
| 3 Months | -10.3% | 1.61% |
| 6 Months | 12.1% | 10.92% |
| 12 Months | 10.00% | 20.88% |
| YTD | -8.25% | 11.05% |
| Rel. Perf. 1m | -0.43 | |
| Rel. Perf. 3m | -1.51 | |
| Rel. Perf. 6m | 0.20 | |
| Rel. Perf. 12m | -0.62 | |
| Spearman 1m | -0.86 | -0.373 |
| Spearman 3m | -0.19 | 0.464 |
Is Bio-Techne a good stock to buy?
Partly, yes. Based on ValueRay Fundamental Analyses, Bio-Techne (NASDAQ:TECH) is currently (October 2024)
ok to buy, but has to be watched. It has a ValueRay Fundamental Rating of 54.30 and therefor a somewhat positive outlook according to the companies health.
Based on ValueRays Analyses, Dividends and Discounted-Cash-Flow, the Fair Value of TECH as of October 2024 is 64.83. This means that TECH is currently overvalued and has a potential downside of -7.58% (Sold with Premium).
Based on ValueRays Analyses, Dividends and Discounted-Cash-Flow, the Fair Value of TECH as of October 2024 is 64.83. This means that TECH is currently overvalued and has a potential downside of -7.58% (Sold with Premium).
Is TECH a buy, sell or hold?
- Strong Buy: 9
- Buy: 2
- Hold: 4
- Sell: 0
- Strong Sell: 0
Values above 0%: TECH is performing better - Values below 0%: TECH is underperforming
Compare TECH with Broad Market Indices
| Symbol | 1w | 1m | 6m | 12m | |
|---|---|---|---|---|---|
| US S&P 500 | SPY | -4.96% | -10.55% | -5.02% | -30.13% |
| US NASDAQ 100 | QQQ | -3.61% | -10.71% | -3.65% | -29.49% |
| US Dow Jones Industrial 30 | DIA | -5.71% | -10.76% | -3.49% | -22.85% |
| German DAX 40 | DBXD | -4.86% | -11.15% | 3.02% | -19.89% |
| UK FTSE 100 | ISFU | -4.37% | -6.09% | -1.44% | -14.20% |
| Shanghai Shenzhen CSI 300 | CSI 300 | 4.55% | -23.74% | 3.72% | -1.34% |
| Hongkong Hang Seng | HSI | 1.05% | -15.90% | -11.79% | -1.07% |
| Japan Nikkei 225 | EXX7 | -3.43% | -10.96% | 8.84% | -12.97% |
| India NIFTY 50 | INDA | -2.55% | -4.01% | 1.52% | -18.10% |
| Brasil Bovespa | EWZ | -3.46% | -0.88% | 14.85% | 8.57% |
TECH Bio-Techne vs. Sectors
| Symbol | 1w | 1m | 6m | 12m | |
|---|---|---|---|---|---|
| Communication Services | XLC | -4.72% | -10.29% | -1.84% | -27.62% |
| Consumer Discretionary | XLY | -4.54% | -9.92% | -3.75% | -22.09% |
| Consumer Staples | XLP | -4.95% | -5.65% | -1.21% | -15.41% |
| Energy | XLE | -2.15% | -10.97% | 14.19% | 6.12% |
| Financial | XLF | -8.22% | -12.22% | -8.81% | -40.28% |
| Health Care | XLV | -3.63% | -5.10% | 1.14% | -10.88% |
| Industrial | XLI | -5.98% | -12.37% | -3.36% | -32.84% |
| Materials | XLB | -5.95% | -11.02% | 1.79% | -21.71% |
| Real Estate | XLRE | -7.23% | -6.24% | -14.43% | -30.42% |
| Technology | XLK | -3.74% | -11.98% | -4.06% | -31.39% |
| Utilities | XLU | -7.60% | -10.54% | -16.99% | -35.03% |
| Aerospace & Defense | XAR | -7.64% | -13.81% | -11.55% | -32.85% |
| Biotech | XBI | -7.08% | -5.19% | -5.41% | -38.62% |
| Homebuilder | XHB | -7.24% | -8.97% | -11.65% | -66.58% |
| Retail | XRT | -8.34% | -9.56% | 0.62% | -23.81% |
Does Bio-Techne outperform its market, is TECH a Sector Leader?
No, over the last 12 months Bio-Techne (TECH) made 10.00%, while its related Sector, the Health Care Sector SPDR Fund (XLV) made 20.88%.
Over the last 3 months TECH made -10.30%, while XLV made 1.61%.
No, over the last 12 months Bio-Techne (TECH) made 10.00%, while its related Sector, the Health Care Sector SPDR Fund (XLV) made 20.88%.
Over the last 3 months TECH made -10.30%, while XLV made 1.61%.
| Period | TECH | XLV | S&P 500 |
|---|---|---|---|
| 1 Month | -6.81% | -1.71% | 3.74% |
| 3 Months | -10.30% | 1.61% | 4.88% |
| 12 Months | 10.00% | 20.88% | 40.13% |